Fundraising FoxBonusbiogroup
1 known investors
Find your way into Bonusbiogroup
Sign up to find every way you can get introduced to Bonusbiogroup
- Your email: who you already know at Bonusbiogroup, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bonusbiogroup team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Bonus Biogroup is a clinical-stage biotechnology company developing tissue engineering and cell therapy products for unmet medical needs related to tissue damage, inflammation, and immune response. Its investigational products include MesenCure, an allogeneic cell therapy targeting inflammation, and BonoFill, a tissue-engineered bone graft for orthopedic and maxillofacial bone defects.
Founders & leadership
DS
Dr. Shai MeretzkiCEO and Founder
Investors · 1
Frequently asked questions
- What does Bonusbiogroup do?
- Bonus Biogroup is a clinical-stage biotechnology company developing tissue engineering and cell therapy products for unmet medical needs related to tissue damage, inflammation, and immune response. Its investigational products include MesenCure, an allogeneic cell therapy targeting inflammation, and BonoFill, a tissue-engineered bone graft for orthopedic and maxillofacial bone defects.
- Who founded Bonusbiogroup?
- Bonusbiogroup was founded by Dr. Shai Meretzki.
- Who are Bonusbiogroup's investors?
- Bonusbiogroup's investors include SIBF (Southern Israel Bridging Fund) VC.